共 50 条
- [31] Subcutaneous treatment with recombinant human erythropoietin - The influence of injection frequency and skin-fold thickness SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY, 1999, 33 (03): : 192 - 196
- [34] COMPARISON BETWEEN INTRAVENOUS AND SUBCUTANEOUS ERYTHROPOIETIN IN DIALYSIS PATIENTS JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1994, 5 (03): : 456 - 456
- [35] THE QUALITY-OF-LIFE OF DIALYSIS PATIENTS TREATED WITH RECOMBINANT-HUMAN-ERYTHROPOIETIN SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY, 1990, : 61 - 65
- [37] PHARMACOKINETICS OF RECOMBINANT HUMAN ERYTHROPOIETIN IN PATIENTS ON CONTINUOUS AMBULATORY PERITONEAL-DIALYSIS LANCET, 1989, 1 (8635): : 425 - 427
- [38] Subcutaneous (SQ) erythropoietin (EPO) in hemodialysis (HD) patients. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1996, 7 (09): : A1278 - A1278
- [40] The effect of recombinant human erythropoietin therapy on serum albumin level in CAPD patients. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1997, 8 : A1267 - A1267